Presentation TCT 2013 Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR? Presenter: Larry Wood October 29, 2013 REGISTER for free or LOG IN to view this content Aortic Valve Presentation TCT 2013 Up Next Presentation TCT 2013 Neurological Events in the CoreValve US Extreme Risk Study Presenter: David Adams October 29, 2013 More slides + Presentation TCT 2013 Valve-in-Valve for Failed Bioprosthetic Valves: Implications of Stented Valve Design Presenter: Vinayak Bapat October 29, 2013 Presentation TCT 2013 TCT-20. Two-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Native Corona... Presenter: Yelin Zhao October 29, 2013 We Recommend
Presentation TCT 2013 Neurological Events in the CoreValve US Extreme Risk Study Presenter: David Adams October 29, 2013
Presentation TCT 2013 Valve-in-Valve for Failed Bioprosthetic Valves: Implications of Stented Valve Design Presenter: Vinayak Bapat October 29, 2013
Presentation TCT 2013 TCT-20. Two-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Native Corona... Presenter: Yelin Zhao October 29, 2013